The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.
Open accessAbstract
Nausea and vomiting are difficult symptoms to manage in patients with advanced cancer. Several classes of antiemetics are available, including phenothiazines, butyrophenones, substituted benzamides and selective serotonin antagonists, as well as corticosteroids. Most patients will respond to either single agents or combinations that frequently include corticosteroids. A minority of patients will have nausea that fails to respond. The atypical antipsychotic, olanzapine, relieves nausea in some patients failing to respond to the usual antiemetics. Two case reports are presented and the rationale for olanzapine's benefit is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine
Bymaster, F. P., Calligaro, D. O., Falcone, J. F., Marsh, R. D., Moore, N. A., Tye, N. C., Seeman, P. M., & Wong, D. T. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00129-n · Cited by 1,061
Dopamine receptor pharmacology
Seeman, P. M., & Tol, H. H. M. V. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90323-9 · Cited by 969
An Open Trial of Olanzapine for the Treatment of Delirium in Hospitalized Cancer Patients
BREITBART, W. S., Tremblay, A., & Gibson, C. (2002) · Psychosomatics · doi:10.1176/appi.psy.43.3.175 · Cited by 288
Beasley, C. M., Hamilton, S. H., Crawford, A. M., Dellva, M. A., Tollefson, G. D., Trân, P. V., Blin, O., & Beuzen, J. N. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00392-6 · Cited by 275
Grond, S., Zech, D. F. J., Diefenbach, C., & Bischoff, A. (1994) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(94)90174-0 · Cited by 265
Fulton, B., & Goa, K. L. (1997) · Drugs · doi:10.2165/00003495-199753020-00007 · Cited by 251
Jin, H., Meyer, J. M., & Jeste, D. V. (2002) · Annals of Clinical Psychiatry · doi:10.1023/a:1015228112495 · Cited by 213
Jin, H., Meyer, J. M., & Jeste, D. V. (2002) · Annals of Clinical Psychiatry · doi:10.3109/10401230209147399 · Cited by 203
ANTIEMETICS: NEUROTRANSMITTER RECEPTOR BINDING PREDICTS THERAPEUTIC ACTIONS
Peroutka, S., & Snyder, S. H. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92206-1 · Cited by 196
Passik, S. D., Lundberg, J., Kirsh, K. L., Theobald, D., Donaghy, K., Holtsclaw, E., Cooper, M., & Dugan, W. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00391-3 · Cited by 154
Dopamine receptor pharmacology.
Seeman, P., & Tol, H. H. M. V. (1993) · PubMed · Cited by 134
Psychotropic drugs and the ECG: focus on the QTc interval
Goodnick, P. J., Parra, F., & Jerry, J. M. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.5.479 · Cited by 120
Brøsen, K., Zeugin, T., & Meyer, U. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.77 · Cited by 114
Lucas, R. A., Gilfillan, D. J., & Bergstrom, R. F. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050527 · Cited by 112
Olanzapine in the Management of Cancer Pain
Khojainova, N., Santiago‐Palma, J., Kornick, C. A., BREITBART, W. S., & Gonzales, G. R. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00378-0 · Cited by 104
Treatment of nausea and vomiting in advanced cancer
Davis, M. P., & Walsh, D. (2000) · Supportive Care in Cancer · doi:10.1007/s005200000151 · Cited by 98
Self-citationNausea and vomiting in advanced cancer
Harris, D. (2010) · British Medical Bulletin · doi:10.1093/bmb/ldq031 · Cited by 96
Dunlop, G. (1990) · Palliative Medicine · doi:10.1177/026921639000400108 · Cited by 91
Gram, L. F., Hansen, M. G. J., Sindrup, S. H., Brøsen, K., Poulsen, J. H., Aaes‐Jørgensen, T., & Overø, K. F. (1993) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199302000-00003 · Cited by 84
An open pilot trial of olanzapine for delirium in the Korean population
Kim, K., Pae, C., Chae, J., Bahk, W., & Jun, T. (2001) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2001.00898.x · Cited by 75
The Safety of Olanzapine Compared With Other Antipsychotic Drugs
Gómez, J. C., Sacristán, J. A., Hernández‐Rivas, J. M., Breier, A. F., Carrasco, P. R., Sáiz, C. A., Carbonell, E. F., & the EFESO Study Group (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0503 · Cited by 72
The role of antipsychotics in treating delirium
Tune, L. E. (2002) · Current Psychiatry Reports · doi:10.1007/s11920-002-0031-8 · Cited by 53
Psychopharmacology of olanzapine
Stephenson, C., & Pilowsky, L. S. (1999) · The British Journal of Psychiatry · doi:10.1192/s0007125000298115 · Cited by 52
Madhusoodanan, S., Brenner, R., Suresh, P., Concepcion, N. M., Florita, C., Menon, G., Kaur, A., Nunez, G., & Reddy, H. (2000) · Annals of Clinical Psychiatry · doi:10.1023/a:1009018809174 · Cited by 43
New-Onset Seizure Associated with Quetiapine and Olanzapine
Hedges, D. W., & Jeppson, K. G. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a207 · Cited by 38
Atypical Neuroleptic Malignant Syndrome Associated with Olanzapine
Reeves, R. R., Torres, R. A., Liberto, V., & Hart, R. H. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.8.641.33211 · Cited by 37
The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteers
Markowitz, J. S., DeVane, C. L., Liston, H. L., Boulton, D. W., & Risch, S. C. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.119815 · Cited by 37
Olanzapine: A New Antipsychotic Agent with Efficacy in the Management of Schizophrenia
Kando, J. C., Shepski, J. C., SATTERLEE, W. G., Patel, J. K., Reams, S. G., & Green, A. I. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703101110 · Cited by 32
Use of olanzapine in non-psychotic psychiatric disorders
Goodnick, P. J., & Barrios, C. A. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.4.667 · Cited by 24
Madhusoodanan, S., Brenner, R., Suresh, P., et al. (2000) · Annals of Clinical Psychiatry · doi:10.3109/10401230009147082 · Cited by 23
Suzuki, A., Otani, K., Ishida, M., Yasui, N., Kondo, T., Mihara, K., Kaneko, S., Inoue, Y., Shibata, M., & Ikeda, K. (1997) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199706000-00003 · Cited by 22
Allan, S. G. (1992) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00050-9 · Cited by 7
Research works printed but not linked: 1
- Passik, 2002, A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients receiving chemo-therapy: a Hoosier Oncology Group Study, Proc ASCO, 21, 374A
Cited by
Sorted by citations
Olanzapine for the prevention of chemotherapy-induced nausea and vomiting.
Navari, R. M., Qin, R., Ruddy, K. J., Liu, H., Powell, S. F., Bajaj, M., Dietrich, L., Biggs, D., Lafky, J. M., & Loprinzi, C. L. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515725 · Cited by 452
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Tan, L., Liu, J., Liu, X., Chen, J., Yan, Z., Yang, H., & Zhang, D. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-131 · Cited by 199
Navari, R. M., Nagy, C. K., & Gray, S. E. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-012-1710-6 · Cited by 181
Navari, R. M., Einhorn, L. H., Passik, S. D., Loehrer, P. J., Johnson, C. S., Mayer, M. L., McClean, J., Vinson, J., & Pletcher, W. (2005) · Supportive Care in Cancer · doi:10.1007/s00520-004-0755-6 · Cited by 146
Chemotherapy-Induced Nausea and Vomiting
Lohr, L. (2008) · The Cancer Journal · doi:10.1097/ppo.0b013e31816a0f07 · Cited by 139
Metadata
- Authors
- Srivastava, M., Brito-Dellan, N., Davis, M. P., Leach, M., & Lagman, R.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- Davis, Mellar P
- Venue
- Journal of Pain and Symptom Management
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 25
- Issue
- 6
- Pages
- 578-582
- ISSN
- 0885-3924 (ISSN-L)
- OpenAlex
- W2028568939
- Cited by
- 106
- References
- 30
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 10 · 2020: 7 · 2019: 2 · 2018: 4 · 2017: 7 · 2016: 9 · 2015: 7 · 2014: 5 · 2013: 5 · 2012: 2
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Pain and Symptom Management (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative and Oncologic Care
- Keywords
- olanzapine, antiemetics, refractory nausea and vomiting, advanced cancer, atypical antipsychotics, corticosteroids, combination antiemetic therapy
- MeSH terms
- Olanzapine, Adult, Aged, Antiemetics, Benzodiazepines, Breast Neoplasms, Female, Humans, Lung Neoplasms, Nausea, Pirenzepine, Vomiting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
